- Activity pressure is positive on the latest completed week.
7762
TWO
Week ended 14 Aug 2026
Weekly Investor Report
PET PHARM BIO · Healthcare · Drug Manufacturers - General
Latest close
50.90 TWD
1.9%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -5.6% below the Trend Line and sits at 15.2% of its 52-week range. The latest completed week returned 1.9%, after a 4.1% four-week move. Near-term considerations: volume confirmation is below normal.
Setup score
29
out of 100
Latest Close
50.90 TWD
14 Aug 2026
1W Return
1.9%
latest completed week
4W Return
4.1%
short-term follow-through
12W Return
-6.8%
quarterly tape
Trend Breadth
32.7%
17 of 52 weeks active
Volume Ratio
0.8x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.9%
Latest completed week; four-week move 4.1%.
Indicator stack
18/52
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -5.6% below the Trend Line and sits at 15.2% of its 52-week range. The latest completed week returned 1.9%, after a 4.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1612-week average 0.13
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.16Current proprietary activity-pressure read.
Buy signals3Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 4.1% over four weeks, -6.8% over 12 weeks, and -14.7% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year17
Trend breadth32.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.22Latest activity-pressure read.
Pressure change-28.1%Four-week change in activity pressure.
Leadership-43.24Latest relative-leadership reading.
RS change2.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment-
No current sentiment snapshot is stored.
Patient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-43.1%Distance below the 52-week high.
13-week volatility3.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
20 Mar
17 Apr
15 May
12 Jun
10 Jul
14 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+23.6%Week of 15 May.
Worst week-15.3%Week of 27 Mar.
Latest week+1.9%Week of 14 Aug.
Shape of recent returns
Strong gains2
Modest gains10
Flat weeks0
Modest losses8
Sharp losses6
Recent vol3.6%13-week weekly-return volatility.
Base vol6.3%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew4.7% / -3.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank26 / 100
Group average0.1%
Trend breadth34.0%
Trend34.0%active weekly trend signals
MD60.0%positive activity pressure
RS9.0%positive relative leadership
Four-week leaders
IndustryTW Drug Manufacturers - General
4-week rank2 / 3
Group average4.6%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD100.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape26/100
Trend, activity pressure, participation, and risk combine to a 26/100 tape read.
Indicator analysis27/100Latest 12-week confirmation: trend 0/12, activity pressure 9/12, relative leadership 0/12.
Activity pressure 0.16; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment50/100No sentiment snapshot is stored yet.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 14 Aug 2026 | 50.90 TWD | 1.9% | 53.90 TWD | 53.53 TWD | 0.22 | -43.24 | 245.6K | Off |
| 7 Aug 2026 | 49.95 TWD | 7.1% | 54.46 TWD | 53.55 TWD | 0.12 | -43.07 | 93.3K | Off |
| 31 Jul 2026 | 46.65 TWD | -5.4% | 55.08 TWD | 53.59 TWD | 0.23 | -46.16 | 226.3K | Off |
| 24 Jul 2026 | 49.30 TWD | 0.8% | 55.81 TWD | 53.66 TWD | 0.31 | -44.49 | 165.1K | Off |
| 17 Jul 2026 | 48.91 TWD | -2.9% | 56.31 TWD | 53.70 TWD | 0.30 | -44.35 | 248.7K | Off |
| 10 Jul 2026 | 50.38 TWD | 3.0% | 56.80 TWD | 53.75 TWD | 0.25 | -46.73 | 473.8K | Off |
| 3 Jul 2026 | 48.91 TWD | -2.0% | 57.24 TWD | 53.78 TWD | 0.06 | -50.45 | 202.5K | Off |
| 26 Jun 2026 | 49.89 TWD | 0.4% | 57.83 TWD | 53.83 TWD | -0.02 | -47.62 | 226.4K | Off |
| 19 Jun 2026 | 49.70 TWD | 0.8% | 58.40 TWD | 53.87 TWD | -0.08 | -50.60 | 231.3K | Off |
| 12 Jun 2026 | 49.30 TWD | -1.2% | 59.13 TWD | 53.91 TWD | 0.00 | -49.11 | 166.3K | Off |
| 5 Jun 2026 | 49.89 TWD | -5.7% | 59.66 TWD | 53.96 TWD | 0.13 | -50.07 | 338.7K | Off |
| 29 May 2026 | 52.93 TWD | -3.1% | 60.51 TWD | 54.00 TWD | -0.12 | -47.19 | 248.4K | Off |
| 22 May 2026 | 54.60 TWD | -5.4% | 61.30 TWD | 54.01 TWD | -0.41 | -42.87 | 935.6K | Off |
| 15 May 2026 | 57.73 TWD | 23.6% | 62.06 TWD | 54.01 TWD | -0.80 | -38.52 | 603.2K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.